Status:

COMPLETED

Palliative Care for Persons With ADRD and CI in SNF

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

National Institute on Aging (NIA)

National Institute of Nursing Research (NINR)

Conditions:

Advance Care Planning

Palliative Care

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

Alzheimer's disease and related dementias (ADRD) are serious, life limiting illnesses with no known cure. Dementia is the fifth-leading cause of death in older adults and the majority of people with a...

Detailed Description

In this pragmatic clinical trial, broadcast notification will be utilized to inform all newly admitted patients at each study site of their participation in this trial. During the admission process, p...

Eligibility Criteria

Inclusion

  • KEY INCLUSION CRITERIA
  • Patients:
  • Admitted for SNF post-acute care at a participating NHs following a recent hospitalization
  • Age ≥ 60 years old
  • Speaks English (if verbal)
  • If non-verbal/unable to participate in a conversation and/or unable to make decisions, a legally authorized representative (LAR)/surrogate decision maker who can make decisions for the patient as determined by ACTs staff
  • Documented ADRD diagnosis in the medical record or history of cognitive impairment (defined as BIMS score ≤ 12)
  • At least one global indicator for PC at SNF admission (provider would not be surprised if patient died within 1 year, believes the patient would benefit from advance care planning or symptom management; frequent hospital or NH SNF admissions; complex care requirements; decline in function; feeding intolerance; unintended decline in weight; or previous hospice assessment or enrollment and subsequent discharge)
  • Surrogate/LAR:
  • ≥18 years old
  • Family member or friend of an eligible patient as determined by ACTs staff
  • Speaks English
  • KEY EXCLUSION CRITERIA
  • Patients:
  • Who have previously received or are referred for PC by their primary care team
  • With a discharge plan within 48 hours of screening
  • Currently receiving hospice care
  • Who do not have one global indicator of need
  • No documented ADRD diagnosis or history of cognitive impairment in the medical record
  • That are non-English speaking, (if verbal)
  • If unable to make decisions, do not have an LAR/surrogate decision maker.
  • Surrogate/LAR:
  • \< 18 years of age
  • Not a family Member or friend of an eligible patient
  • Non-English speaking

Exclusion

    Key Trial Info

    Start Date :

    June 15 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 14 2023

    Estimated Enrollment :

    7 Patients enrolled

    Trial Details

    Trial ID

    NCT05308004

    Start Date

    June 15 2022

    End Date

    December 14 2023

    Last Update

    December 27 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Acts Continuing Care Retirement Communities

    Philadelphia, Pennsylvania, United States, 19014